Michael H.Knight (Mike)

Partner

Washington + 1.202.879.5553

With more than 25 years of experience as an antitrust lawyer in both government and private practice, Mike Knight advises clients on a full range of competition law matters including mergers, joint ventures, competitor collaborations, distribution issues, price discrimination, monopolization, and intellectual property restraints. He routinely represents clients before federal and state antitrust agencies and federal courts. Mike also co-heads Jones Day's Hart-Scott-Rodino Act premerger notification team.

Mike's recent representations include securing antitrust clearance for Cintas Corporation's acquisition of G&K Services and the long-fought acquisition by Hertz of Dollar Thrifty Automotive Group. He also has represented Aetna, Axiall, Conagra, and Indivior, among other clients, on antitrust matters.

Mike served as an assistant director of the Federal Trade Commission's Bureau of Competition from 2003 to 2007, heading the Bureau's Mergers II Division, where he oversaw hundreds of investigations across an array of industries including technology, chemical manufacturing, mining, and agriculture. He was a trial attorney at the U.S. Department of Justice Antitrust Division from 1997 to 2000. In private practice before joining Jones Day, Mike represented technology firms Adobe, NVIDIA, and Synopsys, among other clients.

Mike has held various leadership positions in the American Bar Association's Section of Antitrust Law over the past 18 years and currently serves on the editorial board of the Section's Antitrust Source publication. He writes and speaks frequently on antitrust enforcement topics.

Experience

  • The Stars Group combines with Flutter Entertainment in all share transaction to create world's largest online gaming company by revenueJones Day advised The Stars Group Inc. ("TSG"), listed on Nasdaq and TSX, on an all-share combination with Flutter Entertainment plc ("Flutter"), listed on LSE, implemented through an acquisition of TSG by Flutter pursuant to a Canadian plan of arrangement (the "Combination").
  • Junshi and Lilly to develop and commercialize antibodies for prevention and treatment of COVID-19 coronavirusJones Day represented Shanghai Junshi Biosciences Co., Ltd. in its strategic collaboration and license agreement with Eli Lilly and Company for the development, manufacturing, and commercialization of two antibodies for the prevention and treatment of the COVID-19 SARS-CoV-2 novel coronavirus.
  • U. S. Steel executes Option Agreement for potential joint venture with Stelco Inc. to acquire 25% interest in Minntac at enterprise value of $2.4 billionJones Day represented United States Steel Corporation, an integrated steel producer with major production operations in the United States and Central Europe, in connection with the execution of an Option Agreement for a potential joint venture with Stelco Inc., a vertically integrated Canadian steelmaker.
  • Twin River Worldwide Holdings to acquire three casinos from Eldorado and Caesars for $180 millionJones Day is advising Twin River Worldwide Holdings, Inc. in the $155 million acquisition of Eldorado Shreveport Resort and Casino in Shreveport, Louisiana, and the Mont Bleu Resort Casino & Spa in Lake Tahoe, Nevada, from Eldorado Resorts, Inc., and Bally's Atlantic City Hotel & Casino in New Jersey from Caesars Entertainment Corporation and Vici Properties Inc. for $25 million.
  • OMNOVA acquired by Synthomer plc for $824 millionJones Day advised OMNOVA Solutions Inc. in its $824 million acquisition by Synthomer plc, a United Kingdom-based specialty chemical company.
  • FlaglerCE sold assets to Alta Equipment Holdings Inc.Jones Day advised FlaglerCE Holdings, LLC in the sale of substantially all of its assets to Alta Equipment Holdings Inc.
  • KKR invests in Transphorm, Inc.Jones Day represented Kohlberg Kravis Roberts & Co. L.P. in its recapitalization of, and investment in, Transphorm, Inc.
  • CoStar Group to acquire RentPath from Chapter 11 bankruptcyJones Day is advising CoStar Group, Inc. (NASDAQ: CSGP), the leading provider of commercial real estate information, analytics, and online marketplaces, in connection with its $588 million acquisition of RentPath from a Chapter 11 bankruptcy process.
  • Alcoa sold Gum Springs, Arkansas, facility to Veolia for $250 millionJones Day advised Alcoa Corporation (NYSE: AA), a global leader in bauxite, alumina, and aluminum products, on the $250 million sale of its Gum Springs, Arkansas, waste treatment facility to Veolia ES Technical Solutions.
  • PGT Innovations acquires NewSouth Window SolutionsJones Day advised PGT Innovations, Inc., a national leader in premium windows and doors, including impact-resistant products, in connection with its $92 million cash acquisition of NewSouth Window Solutions, subject to adjustments.
  • TriMas sold Lamons business to First Reserve for $135 millionJones Day advised TriMas Company, LLC, a wholly-owned subsidiary of TriMas Corporation, in its $135 million sale of its Lamons business, a provider of industrial sealing and fastener solutions used in mission-critical, high-consequence applications in the petrochemical, petroleum refining, midstream energy transportation, upstream oil and gas, metropolitan water and wastewater management end markets, to First Reserve, a private equity firm focused on energy investing.
  • CBS and Viacom announce $28 billion all-stock-mergerJones Day is serving as antitrust counsel to CBS Corporation in the $28 billion all-stock merger of CBS and Viacom.
  • Shiseido acquires Drunk Elephant™ for $845 millionJones Day advised Shiseido Americas Corporation in its $845 million acquisition of Drunk Elephant™.
  • BBA Aviation sells Ontic for $1.365 billionJones Day advised BBA Aviation plc ("BBA") in the sale of its Ontic business to an investment fund affiliated with CVC Capital Partners for $1.365 billion.
  • NRC Group Holdings acquired by US Ecology, Inc. for $966 millionJones Day advised NRC Group Holdings Corp. (NYSE American: NRCG) in its acquisition by US Ecology, Inc., a leading North American provider of environmental services to commercial and government entities, pursuant to an all-stock transaction that values NRCG on an enterprise value at $966 million.
  • Roper Technologies sells Gatan to AMETEKJones Day provided antitrust advice to Roper Technologies, Inc. in its sale of microscope peripherals business Gatan, Inc. to AMETEK, Inc.
  • LORD Corporation acquired by Parker Hannifin for $3.675 billionJones Day advised LORD Corporation in its $3.675 billion acquisition by Parker Hannifin Corporation.
  • Boehringer Ingelheim successfully defends FTC "pay-for-delay" investigationThe U.S. Federal Trade Commission ("FTC") ended an 11-year investigation into the settlements of two Hatch-Waxman patent infringement lawsuits between Jones Day's client, Boehringer Ingelheim Pharmaceuticals, Inc., and a generic drug manufacturer.
  • Deltek acquires ComputerEaseJones Day advised Deltek, a subsidiary of Roper Technologies, Inc., a technology company that operates businesses that design and develop software and engineered products for global niche markets, in its acquisition of substantially all of the assets of ComputerEase, a provider of construction accounting software.
  • Arsenal Capital Partners acquires HistoGeneX and Caprion BiosciencesJones Day advised Arsenal Capital Partners on major investments in HistoGeneX and Caprion Biosciences and the subsequent combination of the two businesses.
  • Speaking Engagements

    • November 9, 2016
      Jones Day Global Life Sciences Conference – 2016 Issues & Trends
    • March 10, 2015
      What You Absolutely Positively Must Know About HSR
    • May 21, 2014
      The Interface Between Sector Regulation and Competition Law: The Experience in the US, Europe And Elsewhere, panelist, Canadian Bar Association's 2014 Competition Law Spring Forum
    • November 13, 2013
      2013-2014 Life Sciences Webinar Series: Intellectual Property, Regulatory, and Antitrust Issues in Life Sciences M&A and Capital Markets Transactions
    • September 5, 2013
      Risk Factors for Second Request Merger Investigations by the DOJ and FTC, panelist, ABA Section of Antitrust Program
    • September 12, 2013
      Merger Practice Workshop, panelist, ABA Section of Antitrust Law Program
    • March 27, 2012
      Antitrust for Deal Lawyers, guest lecturer, Boston College Law School
    • January 31, 2012
      Budgeting for eDiscovery: Exploring your Approach to Cost Control and Transparency, panelist, LegalTech New York 2012
    • July 19, 2011
      New DOJ Merger Remedies: Expanded Antitrust Enforcement Tools, panelist, Strafford CLE Webinar
    • June 22, 2011
      Executive Roundtable Series - Growing Your Business: How to Handle Legal and Regulatory Hurdles Both Before and After They Arise
    • March 10, 2011
      TransPerfect Legal Solutions/FTI Technology Second Request Panel, panelist
    • September 27, 2010
      International Competition/Antitrust Update, panelist, CCCA 2010 Corporate Counsel World Summit
    • July 1, 2010
      Horizontal Merger Guidelines: Operating Within the New Antitrust Framework, panelist
    • February 16, 2010
      Executive Roundtable Series: Antitrust in the Obama Administration: Developments in the First Year and What to Expect Next
    • September 15, 2009
      Annual seminar on Antitrust for the Westchester/Southern Connecticut chapter of the Association of Corporate Counsel (WESFACCA)
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.